A variety of pathogenic insults cause synthesis of tumor necrosis factor (TNF)α in the brain, resulting in sickness behavior. Here we used TNFreceptor (TNF-R)2-deficient and wild-type mice to demonstrate that the reduction in social exploration of a novel juvenile, the increase in immobility and the loss of body weight caused by central TNFα (i.c.v., 50 ng/mouse) are blocked by central pre-treatment with the multifunctional peptide, insulin-like growth factor (IGF-I; i.c.v., 300 ng/mouse). These results establish that sickness behavior induced by central TNFα via the TNF-R1 (p55) is directly opposed by IGF-I in the brain.
Introduction
During the course of numerous pathogenic insults, the immune and central nervous systems interact to induce adaptive responses known as sickness behavior (Bluthé et al., 2000; Dantzer, 2004a,b) . This behavioral syndrome consists of a variety of physiological responses, which include symptoms of reduced appetite, weight loss, immobility and reduced interest in the physical and social environment (Dantzer, 2001) . These symptoms of sickness can be mimicked in mice by systemic or central administration of the two major pro-inflammatory cytokines, interleukin (IL)-1β and TNFα (Bluthé et al., 1991 (Bluthé et al., , 2000 (Bluthé et al., , 1994 . In order to develop therapeutic approaches to improve quality of life during infectious, autoimmune and neoplastic diseases, it is important to develop approaches that can oppose the behavioral responses induced by pro-inflammatory cytokines [reviewed in (Kelley et al., 2003) ].
IGF-I is a multifunctional peptide that is essential for normal growth and development and provides neuroprotective and repair properties within the brain (Carro et al., 2003) . IGF-I can oppose the pro-inflammatory activity of TNFα. When given in vivo, IGF-I decreases systemic induction of TNFα during both septic shock (Inoue et al., 1995) and burn wounds (Spies et al., 2001) . Reciprocally, over-expression of TNFα causes retardation of brain growth and alters central nervous system architecture in parallel with depressed IGF-I expression in the cerebellum (Ye et al., 2003) . We have extended these in vivo experiments by showing that IGF-I opposes the sicknessinducing properties of the cytokine inducer lipopolysaccharide (LPS) when both compounds are administered into either the lateral ventricles (i.c.v.) of the brain (Dantzer et al., 1999) or peripherally in the form of an intraperitoneal (i.p.) injection (Johnson et al., 2005) . Sickness behavior induced by LPS requires pro-inflammatory cytokine secretion (Johnson et al., 
